Skip to main content

Table 1 Comparison of the demographic and clinical characteristics of all patients, and of those in the training and testing groups

From: Development and internal validation of a machine-learning-developed model for predicting 1-year mortality after fragility hip fracture

Patient characteristics

Total (N = 492)

Testing (n = 148)

Training(n = 344)

P value

Age (years), mean ± SD

78.4 ± 9.8

78.0 ± 10.1

78.6 ± 9.7

0.511

Female sex, n (%)

355 (72.2%)

104 (70.3%)

251 (73.0%)

0.584

Body mass index (kg/m.2), mean ± SD

22.3 ± 3.9

22.2 ± 4.1

22.4 ± 3.9

0.634

Charlson comorbidity index (CCI) score, n (%)

 - < 3

39 (7.9%)

13 (8.8%)

26 (7.6%)

0.716

 - ≥ 3

453 (92.1%)

135 (91.2%)

318 (92.4%)

 

Pre-injury ambulatory status, n (%)

 - Bedridden

15 (3.0%)

7 (4.7%)

8 (2.3%)

0.556

 - Indoor dependent

43 (8.7%)

10 (6.8%)

33 (9.6%)

 

 - Outdoor dependent

16 (3.3%)

5 (3.4%)

11 (3.2%)

 

 - Indoor independent

145 (29.5%)

45 (30.4%)

100 (29.1%)

 

Assistive device, n (%)

 - No ambulation

15 (3.0%)

7 (4.7%)

8 (2.3%)

0.839

 - Without assistive device

259 (52.6%)

76 (51.4%)

183 (53.2%)

 

 - Wheelchair

10 (2.0%)

2 (1.4%)

8 (2.3%)

 

 - Walker

91 (18.5%)

28 (18.9%)

63 (18.3%)

 

 - Quad cane

3 (0.6%)

1 (0.7%)

2 (0.6%)

 

 - Tripod cane

27 (5.5%)

9 (6.1%)

18 (5.2%)

 

 - Single cane

27 (5.5%)

25 (16.9%)

62 (18.0%)

 

Type of fracture, n (%)

 - Femoral neck fracture

248 (50.4%)

77 (52.0%)

171 (49.7%)

0.883

 - Intertrochanteric fracture

241 (49.0%)

70 (47.3%)

171 (49.7%)

 

 - Subtrochanteric fracture

3 (0.6%)

1 (0.7%)

2 (0.6%)

 

Treatment, n (%)

 - Conservative treatment

32 (6.5%)

11 (7.4%)

21 (6.1%)

0.791

 - Dynamic hip screw

36 (7.3%)

12 (8.1%)

24 (7.0%)

 

 - Cephalomedullary nailing

202 (41.1%)

56 (37.8%)

146 (42.4%)

 

 - Multiple screw fixation

19 (3.9%)

8 (5.4%)

11 (3.2%)

 

 - Hemiarthroplasty

195 (39.6%)

59 (39.9%)

136 (39.5%)

 

 - Total hip arthroplasty

8 (1.6%)

2 (1.4%)

6 (1.7%)

 

Comorbidities, n (%)

 - Chronic kidney disease stage 4 or severe

130 (26.4%)

37 (25.0%)

93 (27.0%)

0.658

 - Heart disease

123 (25.0%)

44 (29.7%)

79 (23.0%)

0.114

 - Cerebrovascular accident

103 (20.9%)

35 (23.6%)

68 (19.8%)

0.336

 - Lung disease

34 (6.9%)

13 (8.8%)

21 (6.1%)

0.332

 - Dementia

81 (16.5%)

16 (10.8%)

65 (18.9%)

0.033

Time to surgery n (%)

 - ≤ 48 h

233 (50.7%)

69 (50.4%)

164 (50.8%)

1.000

 - > 48 h

227 (49.3%)

68 (49.6%)

159 (49.2%)

 

Death, n (%)

62 (12.6%)

19 (12.8%)

43 (12.5%)

1.000

  1. A P value < 0.05 indicates statistical significance
  2. Abbreviation: SD Standard deviation